NCT05891769View on ClinicalTrials.gov

99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2027

Conditions

Parathyroid Adenoma

Interventions

DRUG

18Fluorocholine

18F Fluorocholine 5 mCi ± 20% administered intravenously.

Trial Locations (1)

94305

RECRUITING

Stanford Hospital and Clinics, Stanford

All Listed Sponsors

lead

Andrei Iagaru

OTHER